The hottest Blood Clotting Substack posts right now

Melissa Lucio's case highlights concerns of wrongful convictions in the justice system.
A little-known blood clotting disorder, disseminated intravascular coagulation, may have played a significant role in the case, leading to a misinterpretation of evidence.
Educating jurors on complex medical conditions can be crucial in ensuring fair trials and preventing miscarriages of justice.

Vitamin K is important for putting calcium where it belongs and enabling proper blood clotting.
Vitamin K also plays surprising roles in exercise performance, hormonal health, and cancer prevention.
Consider exploring more about Vitamin K through sources like the mentioned substack website.

Blood clotting is common in COVID-19 cases, especially in moderate to severe situations.
Neutrophil NETs and C3 complement activation play a key role in causing clotting in COVID-19.
Anti-phospholipid antibodies are prevalent in COVID-19 patients and contribute significantly to the clotting cascade.

ACE Inhibitors and ARBs do not increase the presence of ACE2 protein on the cells in the upper respiratory tract, which contradicts previous concerns about worsening COVID-19 risk.
The effects of ACE inhibitors and ARBs on mRNA expression do not directly translate to increased enzyme activity, showing that activity is not solely dependent on mRNA levels.
Studies show a reduced risk of severe COVID-19 outcomes for patients using ACE inhibitors and ARBs, indicating a potential benefit in managing complications associated with the virus.

COVID-19 may cause blood clotting in the liver rather than serious inflammation.
Autopsies showed liver damage in COVID-19 patients, but not due to viral infection.
Research points to serious lung inflammation leading to systemic clotting risk in COVID-19.

Get a weekly roundup of the best Substack posts, by hacker news affinity:

Blood clots may be a significant issue in COVID-19 patients, leading to strokes, especially in younger individuals.
The drug Naproxen (Aleve) has shown potential to inhibit viral growth, though further research is needed.
Naproxen's impact on viral replication in bronchial cells suggests it could help prevent COVID-19 from becoming severe or fatal.